Beth J. Hoffman - 04 Mar 2026 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Director
Signature
/s/ Daniel Hakansson, Attorney-in-fact for Beth J. Hoffman
Issuer symbol
BFRI
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
4
Filing time
06 Mar 2026, 21:28:12 UTC
Previous filing
16 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoffman Beth J. Director 660 MAIN STREET, FIRST FLOOR, WOBURN /s/ Daniel Hakansson, Attorney-in-fact for Beth J. Hoffman 06 Mar 2026 0001885321

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Employee stock option (right to buy) Award +20,000 $0.000000* 20,000 04 Mar 2026 Common Stock 20,000 $0.9000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in twelve equal monthly installments beginning on April 4, 2026.
F2 Options with different terms are not included.